GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Pharma Co Ltd (XKRX:032300) » Definitions » Current Deferred Revenue

Korea Pharma Co (XKRX:032300) Current Deferred Revenue : ₩0 Mil (As of Dec. 2023)


View and export this data going back to 2020. Start your Free Trial

What is Korea Pharma Co Current Deferred Revenue?

Current Deferred Revenue represents collections of cash or other assets related to revenue producing activity for which revenue has not yet been recognized. Generally, an entity records deferred revenue when it receives consideration from a customer before achieving certain criteria that must be met for revenue to be recognized in conformity with GAAP. It can be either current or non-current item. Also called unearned revenue.

Korea Pharma Co's current deferred revenue for the quarter that ended in Dec. 2023 was ₩0 Mil.

Korea Pharma Co Current Deferred Revenue Historical Data

The historical data trend for Korea Pharma Co's Current Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Pharma Co Current Deferred Revenue Chart

Korea Pharma Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Current Deferred Revenue
Get a 7-Day Free Trial - - - - -

Korea Pharma Co Quarterly Data
Mar19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Current Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Korea Pharma Co Current Deferred Revenue Related Terms

Thank you for viewing the detailed overview of Korea Pharma Co's Current Deferred Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Korea Pharma Co (XKRX:032300) Business Description

Traded in Other Exchanges
N/A
Address
8th Floor, 14, Teheran-ro 4-gil, Gangnam-gu, Seoul, KOR
Korea Pharma Co Ltd is a drug manufacturer. The company's products include amino acid drugs; antibiotic drugs; antidotal drugs; antiepileptic drugs; antihistamine drugs; anti-inflammatory drugs; antimicrobial drugs; antiplatelet drugs; circulatory system drugs; cns drugs; dermatological drugs; endocrine drugs; gastrointestinal drugs; hepatic drugs; hormonal drugs; multivitamins; respiratory drugs; skeltal muscle relaxants; specialty drugs; sympathomimetic drugs; and vitamin b1.

Korea Pharma Co (XKRX:032300) Headlines

No Headlines